Duke Rohlen

Duke S.
Rohlen was the founder of CV Ingenuity Corp., founded in 2009, serving as Chief Executive Officer from 2009 to 2013.
Mr. Rohlen was the founder of Tautona Group, founded in 2010, serving as CEO & Managing Partner.
Mr. Rohlen was the founder of Ajax Vascular, Inc., founded in 2013, serving as Chief Executive Officer.
Mr. Rohlen is the founder of Ajax Health LLC, founded in 2017, serving as Managing Director, CEO and Chairman.
Mr. Rohlen is also the founder of Zeus Health LLC..
Mr. Rohlen is currently Chief Executive Officer at Cortex, Inc. Mr. Rohlen is currently Chief Executive Officer & Director at Ajax Health II LLC.
Mr. Rohlen is currently Chief Executive Officer at Cordis-X.
Mr. Rohlen is currently Executive Chairman at Ablacon, Inc., a position held since 2021.
Mr. Rohlen is currently Director at Cordis Corp., a position held since 2023.
Mr. Rohlen is currently Director at Ajax Health III LLC.
Former positions include Chairman & Chief Executive Officer at EPIX Therapeutics, Inc. Chief Executive Officer & Director at Spirox, Inc. from 2013 to 2017.
Director-Business Development at LuMend, Inc. from 1999 to 2000.
Director at Entellus Medical, Inc. from 2017 to 2018.
Director-Business Development at Diboss Corp.
from 1999 to 2000.
Independent Director at Eidos Therapeutics, Inc. from 2020 to 2021.
President-Strategic Operations at FoxHollow Technologies, Inc. from 2006 to 2007.
Consultant at The General Hospital Corp.
from 2000 to 2001.
Education includes undergraduate studies at Stanford University and an MBA from Harvard Business School.